Xenon Pharmaceuticals Inc (XENE) is a publicly traded Healthcare sector company. As of May 20, 2026, XENE trades at $54.67 with a market cap of $5.19B and a P/E ratio of -12.52. XENE moved +1.17% today. Year to date, XENE is +21.49%; over the trailing twelve months it is +74.64%. Its 52-week range spans $26.74 to $63.95. Analyst consensus is strong buy with an average price target of $78.37. Rallies surfaces XENE's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Xenon Pharmaceuticals Inc (XENE) research on Rallies includes live charts, financials, analyst ratings, hedge fund holdings, politician trades, insider activity, news, AI research, and community context. XENE moved +1.17% today. Analyst consensus is strong buy.
| Metric | Value |
|---|---|
| Price | $54.67 |
| Market Cap | $5.19B |
| P/E Ratio | -12.52 |
| EPS | $-4.36 |
| Dividend Yield | 0.00% |
| 52-Week High | $63.95 |
| 52-Week Low | $26.74 |
| Volume | 860.40K |
| Avg Volume | 0 |
| Revenue (TTM) | $7.50M |
| Net Income | $-345.91M |
| Gross Margin | 0.00% |
19 analysts cover XENE: 0 strong buy, 19 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $78.37.